Partnering with Academic Institutions
NanoHarmonics Inc. is finalizing a partnership agreement with a major US University (name to be disclosed upon the finalization of the partnership agreement).
The partnership will be centered around the following major areas of collaborations:
The co-development of specific NanoHarmonics Quantitative Kits and Devices starting with a portable rapid quantitative Malaria diagnostics device that can be deployed in remote areas where the incidence of Malaria is most prevalent.
The co-development of the Data Platform as well as the Data Center that can be used to help create predictive and mitigation models that can be used to help fight future pandemics and and present-day infectious diseases.
- The co-development of the Multiplex Assay designed by the NanoHarmonics team.
- The co-development of a miniaturized version of our existing devices.
Verification and Validations (pre-clinical and clinical).
The partnership will not be limited to pure research and development but will also undertake actual deployments in the commercial markets of the converging technologies in diagnostics, data science, and drug delivery systems to usher in the major shifts in the landscape of the health industry.
We view the partnership as synergistic. NanoHarmonics and its companies will bring the foundational technologies in Quantum-Dot diagnostics, Blockchain-based Data Infrastructure, Nanotechnology-based Drug Delivery Systems, commercialization infrastructure in the US and Asia, and global strategic partners that can operationalize population studies in more than 50 countries.
The University brings access to experts in the academic world that will accelerate the deployment of technologies that can help save lives. The University will provide expertise in Microfluidics, Engineering, Industrial Design, biomarkers identification and isolation for bio-conjugation with Q-dots to accelerate drug development, biomarkers identification and isolation for the development of assays, and many more.
While NanoHarmonics is not dependent on non-dilution capitalization, collectively, NanoHarmonics and the University shall pursue Grants to fund specific initiatives and/or projects. The partnership is expected to be finalized by April 2022.